Midwest Dental Green Bay West in Ashwaubenon, Wisconsin
-
Aurora Sheboygan Prices – CEFTRIAXONE SODIUM 500 MG IJ SOLR is $80.21
At Aurora Medical Center Sheboygan, we prioritize providing our patients with comprehensive financial information upfront. For Charge Code 10002800, regarding CEFTRIAXONE SODIUM 500 MG IJ SOLR, which is classified under revenue code 250 and associated with CPT code J0696, the designated fee stands at $80.21. Our aim through the CompareMedCosts program is to furnish you with all the details you need to make informed healthcare decisions, offering clarity and transparency around the costs associated with your care.
-
Rheumatoid vs. Osteoarthritis: Key Differences Patients Should Understand
This article clarifies the key differences between rheumatoid arthritis (RA) and osteoarthritis (OA) so patients and caregivers can recognize symptoms sooner and pursue the right care. RA is an autoimmune disease that often causes symmetrical joint pain, swelling, warmth, and prolonged morning stiffness, and may bring whole‑body symptoms like fatigue—requiring early, disease‑modifying treatment. OA is a degenerative “wear‑and‑tear” condition that typically affects weight‑bearing or heavily used joints, with pain that worsens with activity and shorter-lived stiffness, managed with targeted pain control, movement, and joint protection. Understanding how they differ in causes, symptoms, testing, and treatment helps you communicate clearly with your clinician, make informed choices, and protect joint function and quality of life.
-
Aurora Sheboygan Prices – KRAS GENE ANALYSIS is $505
At Aurora Medical Center Sheboygan, we prioritize providing our patients with comprehensive financial information upfront. For Charge Code 10004875, regarding KRAS GENE ANALYSIS, which is classified under revenue code 300 and associated with CPT code 81275, the designated fee stands at $505. Our aim through the CompareMedCosts program is to furnish you with all the details you need to make informed healthcare decisions, offering clarity and transparency around the costs associated with your care.
-
FDA warns of a neurosurgical patty shortage through 2026
The FDA says a shortage of neurosurgical patties, sponges, and strips may continue through the end of 2026. The agency is asking hospitals and surgical teams to conserve supplies, prioritize essential cases, and plan for alternatives when appropriate.